← All diseases
Liver, kidneys and digestion
Fatty liver disease (MASH/NASH), advanced
Do you want to receive a message when there is new research about Liver Fat (MASH/NASH), advanced? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research on Liver Steatosis (MASH/NASH), Advanced is available. View what Premium costs.
Publications and studies (2550)
- The association of the healthy food diversity index with the risk of non-alcoholic fatty liver disease among the adult population. (2024/02/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials. (2024/02/01) ♡
- CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chronic liver disease and management with silymarin: an introductory review of a clinical case collection. (2024/01/31) ♡
- Antidiabetic effects of polyherbal mixture made of Centaurium erythraea, Cichorium intybus and Potentilla erecta. (2024/01/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unique Genetic Features of Lean NAFLD: A Review of Mechanisms and Clinical Implications. (2024/01/28) ♡
- lncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChReBP signaling pathway in NAFLD. (2024/01/25) ♡
- Clinical characterization of a hypersensitivity mixed bacterial and fungal dermatitis in a translational model of porcine NASH. (2024/01/24) ♡
- Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study. (2024/01/22) ♡
- Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis. (2024/01/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma. (2024/01/19) ♡
- Causal effects from inflammatory bowel disease on liver function and disease: a two-sample Mendelian randomization study. (2024/01/17) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The impacts of Ramadan fasting for patients with non-alcoholic fatty liver disease (NAFLD): a systematic review. (2024/01/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Maternal obesity induced metabolic disorders in offspring and myeloid reprogramming by epigenetic regulation. (2024/01/16) ♡
- Myeloid cell MHC I expression drives CD8 (+) T cell activation in nonalcoholic steatohepatitis. (2024/01/11) ♡
- Qinlian hongqu decoction ameliorates hyperlipidemia via the IRE1-α/IKKB-β/NF-κB signaling pathway: Network pharmacology and experimental validation. (2024/01/10) ♡
- Zanthoxylum bungeanum ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK/nrf2 signaling. (2024/01/10) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Protective effects of scutellaria-coptis herb couple against non-alcoholic steatohepatitis via activating NRF2 and FXR pathways in vivo and in vitro. (2024/01/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress. (2024/01/10) ♡
- Integrating network analysis and pharmacokinetics to investigate the mechanisms of Danzhi Tiaozhi Decoction in metabolic-associated fatty liver disease (MAFLD). (2024/01/10) ♡
- Chlorogenic Acid Attenuates Hepatic Steatosis by Suppressing ZFP30. (2024/01/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies. (2024/01/10) ♡
- A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones. (2024/01/10) ♡
- Non-alcoholic fatty liver disease causally affects the brain cortical structure: a Mendelian randomization study. (2024/01/08) ♡
- A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD. (2024/01/08) ♡
- Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes. (2024/01/08) ♡
- Association between nonalcoholic fatty liver disease and increased glucose-to-albumin ratio in adults without diabetes. (2024/01/08) ♡
- Loneliness and Social Isolation with Risk of Incident Non-alcoholic Fatty Liver Disease, UK Biobank 2006 to 2022. (2024/01/07) ♡
- The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease. (2024/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neutrophils: tissue and circulating signatures of pediatric non-alcoholic fatty liver disease. (2024/01/04) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis. (2024/01/04) ♡
- Bavachinin protects the liver in NAFLD by promoting regeneration via targeting PCNA. (2024/01/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The Effects of Ginger (Zingiber Officinale Roscoe) on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blinded Placebo-Controlled Clinical Trial. (2024/01/01) ♡
- Si-Ni-San inhibits hepatic Phase expression and lipid accumulation in MAFLD mice through AMPK/p300/SREBP-1c axis. (2024/01/01) ♡
- Comparative Pharmacokinetic Study of Rhubarb Anthraquinones in Normal and Nonalcoholic Fatty Liver Disease Rats. (2024/01/01) ♡
- Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and perilipin 2. (2024/01/01) ♡
- 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-Srebps signaling pathway. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Diagnosis and evaluation of metabolic dysfunction associated steatotic liver disease (MASLD)]. (2024/01/01) ♡
- NME4 mediates metabolic reprogramming and promotes nonalcoholic fatty liver disease progression. (2024/01/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Ramadan fasting model experts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats. (2024/01/01) ♡
- Ginsenoside F2 Restrains Hepatic Steatosis and Inflammation by Altering the Binding Affinity of Liver X Receptor Coregulators. (2024/01/01) ♡
- Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease. (2024/01/01) ♡
- Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease. (2024/01/01) ♡
- An update on the therapeutic role of RNAi in NAFLD/NASH. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-Alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review. (2024/01/01) ♡
- Against Qinlian Decoction Modulates Atherosclerosis and Lipid Metabolism Through Cellular Interplay and Signaling Pathways. (2024/01/01) ♡
- Cpd861 Targeting BCL2 to Alleviate Hepatic Fibrosis: Network Pharmacology, Mendelian Randomization, and Molecular Docking Mechanisms. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research Progress of Chinese Medicine in Treating Chronic Liver Disease by Regulating Autophagy. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD (2024-12-27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD) (2024-12-20) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.